Improving Outcomes for Patients With Severe COVID-19 Acute Respiratory Distress Syndrome Supported With Extracorporeal Membrane Oxygenation.
作者信息
James Les, Smith Deane E
机构信息
Department of Cardiothoracic Surgery, NYU Grossman School of Medicine, 550 First Ave, New York, NY 10016.
Department of Cardiothoracic Surgery, NYU Grossman School of Medicine, 550 First Ave, New York, NY 10016.
出版信息
Ann Thorac Surg. 2023 Apr;115(4):1086-1087. doi: 10.1016/j.athoracsur.2022.06.025. Epub 2022 Jul 3.
Abstract
摘要
相似文献
1
Improving Outcomes for Patients With Severe COVID-19 Acute Respiratory Distress Syndrome Supported With Extracorporeal Membrane Oxygenation.改善接受体外膜肺氧合支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的预后
Ann Thorac Surg. 2023 Apr;115(4):1086-1087. doi: 10.1016/j.athoracsur.2022.06.025. Epub 2022 Jul 3.
2
Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis.用于治疗新型冠状病毒肺炎相关严重急性呼吸窘迫综合征的体外膜肺氧合及血栓形成风险
Br J Anaesth. 2020 Aug;125(2):e260-e262. doi: 10.1016/j.bja.2020.04.079. Epub 2020 May 4.
3
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.体外膜肺氧合治疗 2019 冠状病毒病所致急性呼吸窘迫综合征：一项多中心描述性研究。
Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
4
Turning the Page on Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome due to Severe COVID-19.告别严重新型冠状病毒肺炎所致急性呼吸窘迫综合征的体外膜肺氧合治疗
Am J Respir Crit Care Med. 2022 Aug 1;206(3):236-239. doi: 10.1164/rccm.202205-0906ED.
5
Extracorporeal Membrane Oxygenation instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19-associated Acute Respiratory Distress Syndrome.体外膜肺氧合替代有创机械通气用于一名患有严重新型冠状病毒肺炎相关急性呼吸窘迫综合征的患者
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1571-1573. doi: 10.1164/rccm.202102-0259LE.
6
Treatment of acute respiratory distress syndrome from COVID-19 with extracorporeal membrane oxygenation in obstetrical patients.产科患者中使用体外膜肺氧合治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征
Am J Obstet Gynecol MFM. 2022 Mar;4(2):100537. doi: 10.1016/j.ajogmf.2021.100537. Epub 2021 Nov 20.
7
Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.接受体外膜肺氧合治疗急性呼吸窘迫综合征的异基因造血干细胞移植患者的特征及预后
Crit Care Med. 2017 May;45(5):e500-e507. doi: 10.1097/CCM.0000000000002293.
8
Individualized positive end-expiratory pressure setting in patients with severe acute respiratory distress syndrome supported with veno-venous extracorporeal membrane oxygenation.在接受静脉-静脉体外膜肺氧合支持的严重急性呼吸窘迫综合征患者中进行个体化的呼气末正压设置。
Perfusion. 2021 May;36(4):374-381. doi: 10.1177/0267659120946728. Epub 2020 Aug 10.
9
Correlation between obesity, age and mortality for COVID-19 patients with acute respiratory distress syndrome supported by extracorporeal membrane oxygenation.接受体外膜肺氧合支持的新冠肺炎急性呼吸窘迫综合征患者的肥胖、年龄与死亡率之间的相关性
Asian J Surg. 2023 Jul;46(7):2915-2916. doi: 10.1016/j.asjsur.2023.02.002. Epub 2023 Feb 8.
10
Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure.体外膜肺氧合治疗 COVID-19 合并严重呼吸衰竭患者。
JAMA Surg. 2020 Oct 1;155(10):990-992. doi: 10.1001/jamasurg.2020.3950.
本文引用的文献
1
Survival Benefits of Extracorporeal Membrane Oxygenation for Selected Patients With Severe COVID-19.体外膜肺氧合对部分重症新型冠状病毒肺炎患者的生存获益
Ann Thorac Surg. 2023 Apr;115(4):1085-1086. doi: 10.1016/j.athoracsur.2022.04.012. Epub 2022 Apr 25.
2
One-Year Outcomes With Venovenous Extracorporeal Membrane Oxygenation Support for Severe COVID-19.COVID-19 所致重症患者应用静脉-静脉体外膜肺氧合支持的 1 年结局。
Ann Thorac Surg. 2022 Jul;114(1):70-75. doi: 10.1016/j.athoracsur.2022.01.003. Epub 2022 Mar 10.
3
Venovenous Versus Venoarterial Extracorporeal Membrane Oxygenation for Adult Patients With Acute Respiratory Distress Syndrome Requiring Precannulation Hemodynamic Support: A Review of the ELSO Registry.对于需要预插管血流动力学支持的急性呼吸窘迫综合征成年患者，静脉-静脉与静脉-动脉体外膜肺氧合的比较：ELSO注册研究综述
Ann Thorac Surg. 2017 Aug;104(2):645-649. doi: 10.1016/j.athoracsur.2016.11.006. Epub 2017 Feb 9.
Zotero 插件